Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor

BACKGROUND: Schistosomiasis is a chronic, debilitating parasitic disease infecting more than 200 million people and is second only to malaria in terms of public health importance. Due to the lack of a vaccine, patient therapy is heavily reliant on chemotherapy with praziquantel as the World Health O...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Maha-Hamadien, Lim, Kee-Chong, Sajid, Mohammed, McKerrow, James H, Caffrey, Conor R
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764436/
https://www.ncbi.nlm.nih.gov/pubmed/17214506
http://dx.doi.org/10.1371/journal.pmed.0040014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764436/
https://www.ncbi.nlm.nih.gov/pubmed/17214506
http://dx.doi.org/10.1371/journal.pmed.0040014

Ejemplares similares